7GJ-15851-41279
4 vaccinations
2 coded responses
46 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 276 / NC
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
-
2021-04-13
Dose 2 — Pfizer-BioNTech
- 2021-04-13
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-22
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-07-13
- 2021-10-14
-
2021-11-16
Dose 3 — Moderna
- 2021-11-16
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-02-15
- 2022-05-17
-
2022-09-22
Dose 4 — Moderna
- 2022-09-30
- 2022-10-06
- 2022-10-13
- 2022-10-20
-
2022-10-30
Survey response — day 35, dose 4MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold symtpnsMedDRA releases: 2024-11 · check-in free text available
- 2022-11-03
-
2022-12-22
Survey response — 3 months, dose 4MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, running nose, congestionMedDRA releases: 2024-11 · check-in free text available
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Moderna | No |
| 4 | 2022-09-22 | Moderna | No |
Free text
Release 12 — day 35, dose 4
Symptoms: Cold symtpns
Release 12 — 3 months, dose 4
Symptoms: Cough, running nose, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release